Due to the relatively long elimination half-life, repeated administration of the same dose will lead to plasma concentrations of FSH that are approximately 1.5-2.5 times higher than after single dose administration.
Tingituna suhteliselt pikast poolväärtusajast viib sama annuse korduv manustamine FSH plasmakontsentratsiooni umbes 1, 5… 2, 5 korda kõrgemaks, kui see on pärast üksikannuse manustamist.